TissGeneSummary for ARHGAP24 |
Gene summary |
Basic gene information | Gene symbol | ARHGAP24 |
Gene name | Rho GTPase activating protein 24 | |
Synonyms | FILGAP|RC-GAP72|RCGAP72|p73|p73RhoGAP | |
Cytomap | UCSC genome browser: 4q22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001025616.2, NM_001042669.1,NM_001287805.1,NM_031305.2, | |
Description | RAC1- and CDC42-specific GTPase-activating protein of 72 kDafilamin-A-associated RhoGAPrho GTPase-activating protein 24rho-type GTPase-activating protein 24rhoGAP of 73 kDasarcoma antigen NY-SAR-88 | |
Modification date | 20141207 | |
dbXrefs | MIM : 610586 | |
HGNC : HGNC | ||
Ensembl : ENSG00000138639 | ||
HPRD : 09804 | ||
Vega : OTTHUMG00000130427 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ARHGAP24 | |
BioGPS: 83478 | ||
Pathway | NCI Pathway Interaction Database: ARHGAP24 | |
KEGG: ARHGAP24 | ||
REACTOME: ARHGAP24 | ||
Pathway Commons: ARHGAP24 | ||
Context | iHOP: ARHGAP24 | |
ligand binding site mutation search in PubMed: ARHGAP24 | ||
UCL Cancer Institute: ARHGAP24 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Kidney | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICH | |
Reference showing the relevant tissue of ARHGAP24 | ||
Description by TissGene annotations | Protective TissGene in OS Protective TissGene in RFS Have significant anti-correlated miRNA TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ARHGAP24 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | 2.199134998 | 3.816578998 | -1.617444 | 1.33E-10 | 9.90E-10 |
KIRP | 2.511416248 | 3.716209998 | -1.20479375 | 9.65E-09 | 7.41E-08 |
LUAD | 0.051186722 | 1.437172929 | -1.385986207 | 4.23E-18 | 5.89E-17 |
BRCA | -0.625985177 | 0.66837184 | -1.294357018 | 4.84E-28 | 5.62E-27 |
THCA | -0.150500595 | 2.327860422 | -2.478361017 | 5.31E-21 | 2.67E-19 |
KIRC | 2.319930831 | 3.844066942 | -1.524136111 | 1.16E-30 | 2.32E-29 |
LUSC | 0.005850684 | 1.451636959 | -1.445786275 | 3.36E-12 | 1.49E-11 |
ESCA | -0.263665002 | 1.364034998 | -1.6277 | 0.000585 | 0.010120062 |
BLCA | -1.413975528 | 0.298534998 | -1.712510526 | 0.000135 | 0.001383594 |
STAD | -0.328443127 | 0.700253748 | -1.028696875 | 1.34E-05 | 0.000147728 |
Top |
TissGene-miRNA for ARHGAP24 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
ACC | hsa-miR-302b-3p | MIMAT0000715 | 0.019 | -0.27 | 78 |
ACC | hsa-miR-302b-3p | MIMAT0000715 | 0.019 | -0.27 | 78 |
ACC | hsa-miR-130b-3p | MIMAT0000691 | 0.015 | -0.28 | 78 |
ACC | hsa-miR-130b-3p | MIMAT0000691 | 0.015 | -0.28 | 78 |
LUAD | hsa-miR-205-5p | MIMAT0000266 | 0.023 | -0.3 | 60 |
ACC | hsa-miR-4295 | MIMAT0016844 | 0.0039 | -0.35 | 78 |
ACC | hsa-miR-4295 | MIMAT0016844 | 0.0039 | -0.35 | 78 |
Top |
TissGeneMut for ARHGAP24 |
TissGeneSNV for ARHGAP24 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.D92N | UCEC | 1 |
p.R150L | LUAD | 1 |
p.V156A | PAAD | 1 |
p.G586E | KIRP | 1 |
p.D606V | UCEC | 1 |
p.S502C | LIHC | 1 |
p.R499* | PAAD | 1 |
p.M542I | BLCA | 1 |
p.T35A | TGCT | 1 |
p.R414G | BLCA | 1 |
p.L288S | STAD | 1 |
p.L325F | SKCM | 1 |
p.D92N | UCS | 1 |
p.E51D | KICH | 1 |
p.T728M | UCEC | 1 |
p.S602F | SKCM | 1 |
p.D612H | STAD | 1 |
p.T8M | KIRP | 1 |
p.D161V | STAD | 1 |
p.R499Q | BLCA | 1 |
p.R36Q | BRCA | 1 |
p.M283V | LIHC | 1 |
p.R702* | STAD | 1 |
p.W125* | SKCM | 1 |
p.R702X | STAD | 1 |
p.L104F | CESC | 1 |
p.G485D | STAD | 1 |
p.R216* | BLCA | 1 |
p.R142C | SKCM | 1 |
p.S71Y | UCEC | 1 |
p.K227T | KIRC | 1 |
p.M655T | SKCM | 1 |
p.P597Q | GBM | 1 |
p.Q110K | SKCM | 1 |
p.R146I | UCEC | 1 |
p.F270L | UCEC | 1 |
p.G336D | READ | 1 |
p.P11S | SKCM | 1 |
p.D688G | KIRP | 1 |
p.R702* | UCEC | 1 |
p.E589K | HNSC | 1 |
p.E580K | LUAD | 1 |
p.L105F | LUAD | 1 |
p.R461K | SKCM | 1 |
p.N188S | COAD | 1 |
p.F51L | BLCA | 1 |
p.Q15* | SKCM | 1 |
p.S391F | SKCM | 1 |
p.K82M | LIHC | 1 |
p.I296T | PAAD | 1 |
p.T290M | BRCA | 1 |
p.D533N | ESCA | 1 |
p.P89L | SKCM | 1 |
p.E677K | LUAD | 1 |
p.Q525P | KIRP | 1 |
p.G30X | STAD | 1 |
p.L48F | LUAD | 1 |
p.S570F | SKCM | 1 |
p.G585W | STAD | 1 |
p.G30* | STAD | 1 |
p.L544H | LIHC | 1 |
p.G45W | LUAD | 1 |
p.R499* | UCEC | 1 |
p.R298H | STAD | 1 |
p.R121H | HNSC | 1 |
p.E425X | COAD | 1 |
p.R122Q | UCEC | 1 |
p.K352E | STAD | 1 |
p.L418F | SKCM | 1 |
p.G130X | COAD | 1 |
p.Q548H | HNSC | 1 |
p.Q15X | SKCM | 1 |
p.G16V | UCEC | 1 |
p.H100Y | BRCA | 1 |
p.M701T | UCEC | 1 |
p.S298F | SKCM | 1 |
p.R368K | SKCM | 1 |
p.K324R | UCEC | 1 |
p.K351N | UCEC | 1 |
p.S509F | SKCM | 1 |
p.R702Q | SKCM | 1 |
p.K404N | UCEC | 1 |
p.K422N | UCEC | 1 |
p.D161N | LGG | 1 |
p.R499X | PAAD | 1 |
p.K195N | STAD | 1 |
p.A711V | CHOL | 1 |
p.G24W | LUAD | 1 |
Top |
TissGeneCNV for ARHGAP24 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ARHGAP24 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | DA819158 | ARHGAP24-BANK1 | chr4:86491874 | chr4:102942670 | |
Chimerdb3.0 | ChiTaRs | NA | AK130576 | ARHGAP24-ARHGAP24 | chr4:86646342 | chr4:86396528 | |
Chimerdb3.0 | ChiTaRs | NA | AW749210 | FGD6-ARHGAP24 | chr12:95491543 | chr4:86915995 | |
Chimerdb3.0 | FusionScan | SARC | TCGA-DX-A1KY-01A | ARHGAP24-STAC | 5'UTR-CDS | chr4:86396712 | chr3:36570187 |
TCGAfusionPortal | PRADA | BRCA | TCGA-E2-A1IO-01A | ARHGAP24-C4orf14 | In-frame | Chr4:86643125 | Chr4:57840188 |
Top |
TissGeneNet for ARHGAP24 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ARHGAP24 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ARHGAP24 |
TissGeneDrug for ARHGAP24 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ARHGAP24 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0596263 | Carcinogenesis | 53 | BeFree |
umls:C0027819 | Neuroblastoma | 33 | BeFree |
umls:C0700095 | Central neuroblastoma | 30 | BeFree |
umls:C0006142 | Malignant neoplasm of breast | 19 | BeFree |
umls:C0678222 | Breast Carcinoma | 18 | BeFree |
umls:C2239176 | Liver carcinoma | 18 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 17 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 16 | BeFree |
umls:C0024299 | Lymphoma | 14 | BeFree |
umls:C0029925 | Ovarian Carcinoma | 14 | BeFree |
umls:C0684249 | Carcinoma of lung | 14 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 13 | BeFree |
umls:C1527249 | Colorectal Cancer | 13 | BeFree |
umls:C0007137 | Squamous cell carcinoma | 11 | BeFree |
umls:C1140680 | Malignant neoplasm of ovary | 11 | BeFree |
umls:C0023467 | Leukemia, Myelocytic, Acute | 10 | BeFree |
umls:C0025202 | melanoma | 9 | BeFree |
umls:C0023449 | Acute lymphocytic leukemia | 7 | BeFree |
umls:C0178874 | Tumor Progression | 7 | BeFree |
umls:C0600139 | Prostate carcinoma | 7 | BeFree |
umls:C0005684 | Malignant neoplasm of urinary bladder | 6 | BeFree |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 6 | BeFree |
umls:C0023434 | Chronic Lymphocytic Leukemia | 6 | BeFree |
umls:C0376545 | Hematologic Neoplasms | 6 | BeFree |
umls:C0699791 | Stomach Carcinoma | 6 | BeFree |
umls:C0699885 | Carcinoma of bladder | 6 | BeFree |
umls:C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 6 | BeFree,GAD |
umls:C0001418 | Adenocarcinoma | 5 | BeFree |
umls:C0007115 | Malignant neoplasm of thyroid | 5 | BeFree |
umls:C0025286 | Meningioma | 5 | BeFree |
umls:C0026764 | Multiple Myeloma | 5 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 5 | BeFree |
umls:C0549473 | Thyroid carcinoma | 5 | BeFree |
umls:C0686619 | Secondary malignant neoplasm of lymph node | 5 | BeFree |
umls:C1168401 | Squamous cell carcinoma of the head and neck | 5 | BeFree |
umls:C0007847 | Malignant tumor of cervix | 4 | BeFree |
umls:C0023418 | leukemia | 4 | BeFree |
umls:C0024623 | Malignant neoplasm of stomach | 4 | BeFree |
umls:C0220641 | Lip and Oral Cavity Carcinoma | 4 | BeFree |
umls:C0302592 | Cervix carcinoma | 4 | BeFree |
umls:C0546837 | Malignant neoplasm of esophagus | 4 | BeFree |
umls:C0677886 | Epithelial ovarian cancer | 4 | BeFree |
umls:C0001430 | Adenoma | 3 | BeFree |
umls:C0004114 | Astrocytoma | 3 | BeFree |
umls:C0014859 | Esophageal Neoplasms | 3 | BeFree |
umls:C0017638 | Glioma | 3 | BeFree |
umls:C0023470 | Myeloid Leukemia | 3 | BeFree |
umls:C0028945 | oligodendroglioma | 3 | BeFree |
umls:C0152013 | Adenocarcinoma of lung (disorder) | 3 | BeFree |
umls:C0152018 | Esophageal carcinoma | 3 | BeFree |
umls:C0153381 | Malignant neoplasm of mouth | 3 | BeFree |
umls:C0206698 | Cholangiocarcinoma | 3 | BeFree |
umls:C0279626 | Squamous cell carcinoma of esophagus | 3 | BeFree |
umls:C0280100 | Solid tumour | 3 | BeFree |
umls:C0751396 | Well Differentiated Oligodendroglioma | 3 | BeFree |
umls:C0919267 | ovarian neoplasm | 3 | BeFree |
umls:C1519670 | Tumor Angiogenesis | 3 | BeFree |
umls:C1762616 | Meningioma, benign, no ICD-O subtype | 3 | BeFree |
umls:C0006118 | Brain Neoplasms | 2 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 2 | BeFree |
umls:C0014474 | Ependymoma | 2 | BeFree |
umls:C0017152 | Gastritis | 2 | BeFree |
umls:C0019163 | Hepatitis B | 2 | BeFree |
umls:C0023473 | Myeloid Leukemia, Chronic | 2 | BeFree |
umls:C0023487 | Acute Promyelocytic Leukemia | 2 | BeFree |
umls:C0027430 | Nasal Polyps | 2 | BeFree |
umls:C0027962 | Melanocytic nevus | 2 | BeFree |
umls:C0029463 | Osteosarcoma | 2 | BeFree |
umls:C0079772 | T-Cell Lymphoma | 2 | BeFree |
umls:C0153382 | Malignant neoplasm of oropharynx | 2 | BeFree |
umls:C0235974 | Pancreatic carcinoma | 2 | BeFree |
umls:C0278701 | Gastric Adenocarcinoma | 2 | BeFree |
umls:C0343641 | Human papilloma virus infection | 2 | BeFree |
umls:C0346647 | Malignant neoplasm of pancreas | 2 | BeFree |
umls:C0376544 | Hematopoietic Neoplasms | 2 | BeFree |
umls:C0429087 | Electrocardiogram: P-R interval | 2 | GWASCAT |
umls:C0585442 | Osteosarcoma of bone | 2 | BeFree |
umls:C0598766 | Leukemogenesis | 2 | BeFree |
umls:C2349952 | Oropharyngeal Carcinoma | 2 | BeFree |
umls:C3539878 | Triple Negative Breast Neoplasms | 2 | BeFree |
umls:C0002395 | Alzheimer's Disease | 1 | BeFree |
umls:C0003850 | Arteriosclerosis | 1 | BeFree |
umls:C0004153 | Atherosclerosis | 1 | BeFree |
umls:C0005699 | Blast Phase | 1 | BeFree |
umls:C0007102 | Malignant tumor of colon | 1 | BeFree |
umls:C0007103 | Malignant neoplasm of endometrium | 1 | BeFree |
umls:C0007113 | Rectal Carcinoma | 1 | BeFree |
umls:C0007121 | Bronchogenic Carcinoma | 1 | BeFree |
umls:C0007129 | Merkel cell carcinoma | 1 | BeFree |
umls:C0009404 | Colorectal Neoplasms | 1 | BeFree |
umls:C0010606 | Adenoid Cystic Carcinoma | 1 | BeFree |
umls:C0015625 | Fanconi Anemia | 1 | BeFree |
umls:C0017185 | Gastrointestinal Neoplasms | 1 | BeFree |
umls:C0017636 | Glioblastoma | 1 | BeFree |
umls:C0017668 | Focal glomerulosclerosis | 1 | BeFree |
umls:C0018133 | Graft-vs-Host Disease | 1 | BeFree |
umls:C0019196 | Hepatitis C | 1 | BeFree |
umls:C0020175 | Hunger | 1 | BeFree |
umls:C0022658 | Kidney Diseases | 1 | BeFree |
umls:C0023448 | Lymphoid leukemia | 1 | BeFree |
umls:C0023474 | Leukemia, Myeloid, Chronic-Phase | 1 | BeFree |
umls:C0023531 | Leukoplakia | 1 | BeFree |
umls:C0023890 | Liver Cirrhosis | 1 | BeFree |
umls:C0023903 | Liver neoplasms | 1 | BeFree |
umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | BeFree |
umls:C0024314 | Lymphoproliferative Disorders | 1 | BeFree |
umls:C0025149 | Medulloblastoma | 1 | BeFree |
umls:C0026269 | Mitral Valve Stenosis | 1 | BeFree |
umls:C0026277 | Mixed Salivary Gland Tumor | 1 | BeFree |
umls:C0026769 | Multiple Sclerosis | 1 | BeFree |
umls:C0030521 | Parathyroid Neoplasms | 1 | BeFree |
umls:C0032927 | Precancerous Conditions | 1 | BeFree |
umls:C0033027 | Preleukemia | 1 | BeFree |
umls:C0035335 | Retinoblastoma | 1 | BeFree |
umls:C0038356 | Stomach Neoplasms | 1 | BeFree |
umls:C0040136 | Thyroid Neoplasm | 1 | BeFree |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |
umls:C0042373 | Vascular Diseases | 1 | BeFree |
umls:C0079731 | B-Cell Lymphomas | 1 | BeFree |
umls:C0079744 | Diffuse Large B-Cell Lymphoma | 1 | BeFree |
umls:C0079745 | Lymphoma, Large-Cell, Follicular | 1 | BeFree |
umls:C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | BeFree |
umls:C0085669 | Acute leukemia | 1 | BeFree |
umls:C0149678 | Epstein-Barr Virus Infections | 1 | BeFree |
umls:C0151546 | Oral Cavity Carcinoma | 1 | BeFree |
umls:C0153452 | Malignant neoplasm of gallbladder | 1 | BeFree |
umls:C0178468 | Autoimmune thyroid disease | 1 | BeFree |
umls:C0235782 | Gallbladder Carcinoma | 1 | BeFree |
umls:C0238448 | Testicular embryonal carcinoma | 1 | BeFree |
umls:C0262587 | Parathyroid Adenoma | 1 | BeFree |
umls:C0278601 | Inflammatory Breast Carcinoma | 1 | BeFree |
umls:C0278687 | Ovarian epithelial cancer stage III | 1 | BeFree |
umls:C0278883 | Metastatic melanoma | 1 | BeFree |
umls:C0278996 | Cancer of Head and Neck | 1 | BeFree |
umls:C0280313 | Squamous cell carcinoma of oropharynx | 1 | BeFree |
umls:C0333497 | Segmental glomerulosclerosis | 1 | BeFree |
umls:C0334583 | Pilocytic Astrocytoma | 1 | BeFree |
umls:C0334590 | Anaplastic Oligodendroglioma | 1 | BeFree |
umls:C0346957 | Disseminated Malignant Neoplasm | 1 | BeFree |
umls:C0476089 | Endometrial Carcinoma | 1 | BeFree |
umls:C0549379 | Recurrent Carcinoma | 1 | BeFree |
umls:C0553723 | Squamous cell carcinoma of skin | 1 | BeFree |
umls:C0585362 | Squamous cell carcinoma of mouth | 1 | BeFree |
umls:C0699790 | Colon Carcinoma | 1 | BeFree |
umls:C0740457 | Malignant neoplasm of kidney | 1 | BeFree |
umls:C0751688 | Malignant Squamous Cell Neoplasm | 1 | BeFree |
umls:C0850666 | Helicobacter pylori infection | 1 | BeFree |
umls:C0860207 | Drug-Induced Liver Injury | 1 | GAD |
umls:C0862506 | Borderline ovarian tumour | 1 | BeFree |
umls:C0878500 | Intraepithelial Neoplasia | 1 | BeFree |
umls:C0948216 | Ovarian adenocarcinoma | 1 | BeFree |
umls:C1292769 | Precursor B-cell lymphoblastic leukemia | 1 | BeFree |
umls:C1336076 | Sporadic Breast Carcinoma | 1 | BeFree |
umls:C1337013 | Differentiated Thyroid Gland Carcinoma | 1 | BeFree |
umls:C1378703 | Renal carcinoma | 1 | BeFree |
umls:C1458155 | Mammary Neoplasms | 1 | BeFree |
umls:C1510586 | Autism Spectrum Disorders | 1 | BeFree |
umls:C1512409 | Hepatocarcinogenesis | 1 | BeFree |
umls:C1623038 | Cirrhosis | 1 | BeFree |
umls:C1654637 | androgen independent prostate cancer | 1 | BeFree |
umls:C1883486 | Uterine Corpus Cancer | 1 | BeFree |
umls:C2752147 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | 1 | BeFree |
umls:C2931822 | Nasopharyngeal carcinoma | 1 | BeFree |
umls:C3150911 | GASTRIC CANCER, INTESTINAL | 1 | BeFree |
umls:C3463824 | MYELODYSPLASTIC SYNDROME | 1 | BeFree |
umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 1 | BeFree |
umls:C3539909 | Allergic disposition | 1 | BeFree |